Primary Prevention of Gastric Variceal Bleeding : Endoscopic Treatment Versus Non-selective Beta-blocker
Who is this study for? Adult patients with gastric variceal bleeding and cirrhosis
What treatments are being studied? Propranolol
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
Design a randomized trial to compare the effect of endoscopic cyanoacrylate injection obliteration versus non-selective beta-blocker in the primary prevention of gastric variceal bleeding.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• patients with live cirrhosis and/or hepatoma
• Aged 18 to 80, who had endoscopy-Proven EV(-)GV(+)or EV\<GV
Locations
Other Locations
Taiwan
Veteran General Hospital-Taipei
RECRUITING
Taipei
Contact Information
Primary
Ming-Chih Hou, MD
mchou@vghtpe.gov.tw
886-2-28712111
Backup
Han-Chieh Lin, MD
hclin@vghtpe.gov.tw
886-2-28712111
Time Frame
Start Date: 2010-04
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 120
Treatments
No_intervention: Cyanoacrylate
Endoscopic Cyanoacrylate Injection treatment of primary prevention GVB
Active_comparator: Propranolol
Propranolol is used for primary prevention of GVB
Related Therapeutic Areas
Sponsors
Leads: Taipei Veterans General Hospital, Taiwan